EMFACE and Ulthera Prime Contraindications: What Every Patient Should Know First
Why Contraindications Matter as Much as the Treatment Itself
I always tell patients that "a safe treatment" doesn't automatically mean "safe for everyone." The safety of EMFACE and Ulthera Prime depends heavily on correct patient screening from the very start. Overlooking these contraindications can lead to unexpected complications — from interference with implanted electronic devices to aggravating an underlying condition. So today I want to walk through the key contraindications of both technologies in plain, understandable terms.
EMFACE Contraindications
EMFACE combines HIFES (High-Intensity Facial Electrical Stimulation) with radiofrequency to stimulate facial muscles and skin simultaneously. Because it relies primarily on electrical conduction, its contraindications relate specifically to electronic devices and metal:
- Patients with a pacemaker or other implanted electronic device, since the electrical current used may interfere with these devices.
- Patients with metal implants in the treatment area, as metal can disrupt the distribution of electrical energy.
- Patients with active infection or unhealed wounds in the treatment area.
- Pregnant or breastfeeding patients.
- Patients who underwent surgery in the treatment area within the past 3 months, or whose surgical wounds have not fully healed.
- Patients with a current or past history of skin cancer, other types of cancer, or moles with malignant features.
Ulthera Prime Contraindications
Ulthera Prime uses High-Intensity Focused Ultrasound (HIFU) to deliver thermal energy directly to the SMAS layer. Its main contraindications relate to skin condition in the treatment area and implanted devices:
- Patients with open wounds or lesions in the treatment area.
- Patients with severe or cystic acne in the treatment area.
- Patients with active electronic implants, such as pacemakers or defibrillators, in the treatment area.
- Patients with metallic implants in the treatment area.
Beyond these core contraindications, there are additional precautions physicians must consider: Ulthera treatment directly over areas with mechanical implants, previously injected dermal fillers, or breast implants is not recommended, since safety data in these areas is limited. Treatment energy directly over an existing keloid is also not recommended, and extra caution is warranted in patients on anticoagulant medication, as this population hasn't been sufficiently studied for safety.
As for pregnant or breastfeeding patients, while there's no clear evidence that Ulthera is harmful, most physicians apply the precautionary principle and defer treatment until after pregnancy and breastfeeding.
What Both Technologies Have in Common
Both technologies share three common contraindication themes: electronic or metal implants in the treatment area, infection or open wounds in the treatment area, and precaution during pregnancy or breastfeeding. This reflects a broader principle: whether the technology relies on electrical stimulation (EMFACE) or focused ultrasound (Ulthera Prime), a thorough medical history is essential before any treatment begins.
My Recommendation
Before undergoing either EMFACE or Ulthera Prime, I recommend disclosing your full surgical history, any implanted medical devices, current medications, and any recent filler injections or other treatments in nearby areas — so your physician can properly assess suitability. Don't withhold information that seems unrelated; small details can sometimes matter significantly for treatment safety.
Final Thoughts
The contraindications for EMFACE and Ulthera Prime aren't meant to restrict access to treatment — they exist to protect each patient's individual safety. Good care always starts with a thorough medical history and assessment by a qualified physician, not simply choosing whichever technology is currently trending.